Winter Wonderland in the Heart of NYC: The Empire State Building Celebrates the Holiday Season with Extravagant Holiday Décor, Festive Movie Screenings, Special Lightings, and More
2.12.2024 22:30:00 CET | Business Wire | Press release
The Empire State Building (ESB) today announced details for its fan-favorite holiday festivities with over-the-top decorations, festive pop-ups, classic movie screenings, and special tower lightings.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241202020008/en/
Winter Wonderland in the Heart of NYC: The Empire State Building Celebrates the Holiday Season with Extravagant Holiday Décor, Festive Movie Screenings, Special Lightings, and More (Photo: Business Wire)
“There is no place quite like New York to spend the holidays, and the Empire State Building tops the list of things to do in NYC,” said Jean-Yves Ghazi, president of the Empire State Building Observatory. “From photos with Santa to classic film screenings, guests will make holiday memories to last a lifetime with the best views in New York City.”
Topped with Tinsel
Every corner of the Empire State Building Observatory will be adorned in festive holiday decorations with shining wreaths, lights, tinsel, bows, and a giant menorah at the two-story building model. As they make their way through the Observatory Experience’s immersive exhibits, guests can pose for holiday photos in a dedicated corner of the 80th Floor with Christmas trees, snowflakes, presents, and a cozy fireplace backdrop inspired by Santa’s workshop.
Once they reach the iconic 86th Floor Observatory, guests can pose in a dedicated Ghirardelli corner decorated with a candy cane arch, holiday greenery, twinkle lights, and Ghirardelli’s fan-favorite peppermint bark squares.
Guests will conclude their Observatory visit in the building’s famed Fifth Avenue Lobby – featured in the holiday classic, “Elf” – that is decorated with classic holiday decorations like hanging twinkle lights, wreaths, and an oversized Christmas tree. The iconic Fifth Avenue Windows depict scenes of sleighs full of elaborately wrapped gifts, teddy bears, and holiday ice cream sundaes by Ghirardelli Chocolate.
Tenants and visitors who pass through the Fifth Avenue Lobby from Monday through Friday in the month of December will hear holiday tunes performed by professional pianists.
The Man with the Bag
On Nov. 30 and Dec. 7, 9, 11, 14, 16, 18, and 20, Santa Claus himself will spread holiday cheer and pose for photos with Observatory guests in his dedicated corner on the building’s 80th Floor. More information on Santa visits can be found at esbholiday.com.
Baby, It’s Cold Outside
From Nov. 13 throughout the holiday season, Ghirardelli Chocolate will reside on the Empire State Building’s 86th Floor Observatory every day from 10 a.m.-1 p.m. and 5-8 p.m. The beloved chocolatier will offer their classic hot cocoa and peppermint hot cocoa to guests as they take in New York City’s best views from the comfort of the heated open-air Observatory.
Starbucks Reserve®Winter Wonderland
Holiday magic comes alive in the iconic Starbucks Reserve® Empire State Building store with the new, limited-time Winter Wonderland pop-up experience. Located at the Coffee & Cocktail Lounge on the second level of the store, Starbucks Reserve® Winter Wonderland highlights the coffee journey, from bean to cup. Exclusive to the experience is the new Empire State Cocoa Cocktail that features dark chocolate and steamed milk infused with Hennessy VS Cognac, topped with whipped cream, and served with a side of Royal Combier liqueur and dark chocolate bites.
Holiday Classics
Fans can purchase tickets to view classic holiday films on the Observatory’s 80th Floor which include:
- “Elf” on Dec. 2, 8, 10, 15, and 17
- “Home Alone 2: Lost in New York” on Dec. 5 and 11
- And “The Nightmare Before Christmas” on Dec. 13.
Tickets to these special holiday screenings will each include themed drinks and snacks, and full access to ESB’s second floor museum and the 86th and 102nd Floor Observatories.
Special Lightings
The Empire State Building’s iconic tower lights will shine throughout the holiday season with dedicated lightings for Thanksgiving, Chanukah, Christmas, and New Year’s Eve. The building will also debut its annual holiday music-to-light show. Text CONNECT to 274-16 to receive real-time information about each Empire State Building tower lighting.
The Empire State Building’s world-famous Observatory Experience underwent a $165 million reimagination that added a new interactive museum with nine galleries, bespoke host uniforms, and a new 102nd Floor Observatory with unmatched views from the heart of New York City. The iconic Observatory Experience was recently voted the number one attraction in the world – and number one in the U.S. for the third consecutive year – in the 2024 Tripadvisor Travelers’ Choice Awards: Best of the Best Things to Do.
Hi-res imagery can be downloaded here.
More information about the Empire State Building can be found online.
About the Empire State Building
The Empire State Building, the “World's Most Famous Building," owned by Empire State Realty Trust, Inc. (ESRT: NYSE), soars 1,454 feet above Midtown Manhattan from base to antenna. The $165 million reimagination of the Empire State Building Observatory Experience created an all-new experience with a dedicated guest entrance, an interactive museum with nine galleries, and a redesigned 102nd Floor Observatory with floor-to-ceiling windows. The journey to the world-famous 86th Floor Observatory, the only 360-degree, open-air observatory with views of New York and beyond, orients visitors for their entire New York City experience and covers everything from the building's iconic history to its current place in pop culture. The Empire State Building Observatory Experience welcomes millions of visitors each year and was declared the #1 Attraction in the World – and #1 Attraction in the U.S. for the third consecutive year – in Tripadvisor’s Travelers’ Choice Awards: Best of the Best Things to Do, "America's Favorite Building" by the American Institute of Architects, the world's most popular travel destination by Uber, and the #1 New York City attraction in Lonely Planet’s Ultimate Travel List.
Since 2011, the building has been fully powered by renewable wind electricity, and its many floors house a diverse array of office tenants such as LinkedIn and Shutterstock, as well as retail options like STATE Grill and Bar, Tacombi, and Starbucks. For more information and Observatory Experience tickets visit esbnyc.com or follow the building's Facebook, X (formerly Twitter), Instagram, Weibo, YouTube, or TikTok.
Source: Empire State Realty Trust, Inc.
Category: Observatory
View source version on businesswire.com: https://www.businesswire.com/news/home/20241202020008/en/

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release
Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release
News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi
Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo
IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 12:50:00 CEST | Press release
Transaction advances portfolio transformation, sharpens focus on higher-growth, higher-margin businesses, strengthens balance sheet, and enhances value creation for shareholders IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio tr
BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 12:00:00 CEST | Press release
Data represents the longest reported follow-up for a next-generation BTK inhibitor in CLL, showing sustained disease control and benefit that extends beyond first-line therapyBRUKINSA plus next-generation BCL2 inhibitor sonrotoclax (ZS) delivered deep, durable, and rapid uMRD responses, raising the bar for potential time-limited treatments in CLLData reinforce BeOne’s leadership in CLL and the strength of its foundational hematology franchise BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 pati
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom